Testing a new malaria vaccine in Thai adults
Part of Infections clinical trials.
This trial tests a new malaria vaccine in healthy Thai adults. Participants will receive the vaccine and then be exposed to malaria in a controlled setting to see if the vaccine protects them. If you qualify, you'll be closely monitored and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 20 and 55 years old and live in Thailand.
- You have completed at least high school and can read and write in Thai.
- You must have a specific blood type marker called Duffy antigen (a simple blood test will check this).
- If you are a woman who can have children, you must agree to use effective birth control during the study and for 3 months after the malaria challenge.
- You must be willing to stay in Bangkok or nearby for about 2 months and be admitted to the hospital for monitoring after the malaria challenge.
- You must agree not to donate blood during the study and for 1 year after starting antimalarial treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
This study will expose healthy adults to a small number of mosquito bites carrying the P. vivax malaria parasite to learn how many bites are needed to cause infection. Participants will be closely monitored and treated in the hospital to ensure safety.
This trial tests a new malaria vaccine in healthy adults. It includes a controlled malaria infection to see how well the vaccine works. Participation lasts about a year with follow-up visits.
This trial tests a new malaria vaccine in healthy adults. It's an early (Phase 1) study, so it's mainly checking safety and how the body responds to the vaccine, not whether it prevents malaria yet.
This study tests whether adding an experimental vaccine can help your immune system control HIV during a temporary break from your antiretroviral therapy (ART). If you have been on ART since shortly after infection with a suppressed viral load, this trial could help you understand if a 'functional cure' is possible.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
Hear when a new Plasmodium Vivax Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.